Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters

被引:45
作者
Gauthier, C
Weber, S
Alarco, AM
Alqawi, O
Daoud, R
Georges, E
Raymond, M
机构
[1] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada
[2] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada
关键词
D O I
10.1128/AAC.47.5.1543-1554.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Candida albicans CDR1 and CDR2 genes code for highly homologous ATP-binding cassette (ABC) transporters which are overexpressed in azole-resistant clinical isolates and which confer resistance to multiple drugs by actively transporting their substrates out of the cells. These transporters are formed by two homologous halves, each with an intracellular domain containing an ATP-binding site followed by a membrane-associated domain. We have expressed Cdr1p and Cdr2p in Saccharomyces cerevisiae to investigate their functions. The two proteins were properly expressed and functional, as determined by Western blotting, drug susceptibility assays, and rhodamine efflux. Using total membrane proteins from these transformants, we showed that Cdr1p and Cdr2p bind to the photoreactive analogue of rhodamine 123, [I-125]iodoaryl azidorhodamine 123 (IAARh123). IAARh123 photoaffinity labeling of membranes prepared from cells expressing either the N half or the C half of Cdr2p, or both, demonstrated that both halves contribute to rhodamine binding and can bind to rhodamine independently. Interestingly, Cdr1p was found to confer hypersusceptibility to FK520, an immunosuppressant and antifungal agent, whereas Cdr2p conferred resistance to this compound, uncovering a major functional difference between the two transporters. Furthermore, when administered in combination with azoles, FK520 sensitized cells expressing CDRI but not those expressing CDR2. Finally, we showed that Cdr2p confers hypersusceptibility to hydrogen peroxide and resistance to diamide, while Cdr1p has no effect against these oxidative agents. Taken together, our results demonstrate that, despite a high level of structural conservation, Cdr1p and Cdr2p exhibit major functional differences, suggesting distinct biological functions.
引用
收藏
页码:1543 / 1554
页数:12
相关论文
共 74 条
[1]   Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance [J].
Albertson, GD ;
Niimi, M ;
Cannon, RD ;
Jenkinson, HF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2835-2841
[2]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[3]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[4]  
ARCECI RJ, 1992, BLOOD, V80, P1528
[5]   Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans [J].
Arndt, C ;
Cruz, MC ;
Cardenas, ME ;
Heitman, J .
MICROBIOLOGY-SGM, 1999, 145 :1989-2000
[6]   Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model [J].
Barchiesi, F ;
Najvar, LK ;
Luther, MF ;
Scalise, G ;
Rinaldi, MG ;
Graybill, JR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1317-1320
[7]   Inventory and function of yeast ABC proteins: about sex, stress, pleiotropic drug and heavy metal resistance [J].
Bauer, BE ;
Wolfger, H ;
Kuchler, K .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (02) :217-236
[8]   REDUCED VIRULENCE OF CANDIDA-ALBICANS MUTANTS AFFECTED IN MULTIDRUG-RESISTANCE [J].
BECKER, JM ;
HENRY, LK ;
JIANG, WD ;
KOLTIN, Y .
INFECTION AND IMMUNITY, 1995, 63 (11) :4515-4518
[9]   MUTATIONAL ANALYSIS OF THE YEAST A-FACTOR TRANSPORTER STE6, A MEMBER OF THE ATP BINDING CASSETTE (ABC) PROTEIN SUPERFAMILY [J].
BERKOWER, C ;
MICHAELIS, S .
EMBO JOURNAL, 1991, 10 (12) :3777-3785
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3